United States Biotechnology & Medical Research

Mirum Pharmaceuticals Inc (MIRM)

Track

Over the past 90 days, Mirum Pharmaceuticals Inc. insiders have executed 31 transactions, all of which were sales totaling approximately $15.88 million. Key executives, including the CEO and CFO, conducted these planned and proposed sales. This activity follows the company's last earnings report, which showed an EPS miss, amid a 5% decline in stock price.
Ticker: MIRM Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Mirum Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 3 Aug 2026
Value US$3,856,539.85 | Price 253.29 | Shares 53,656 (-43.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-05 2026-08-03 PlS Planned sale
2.7
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
53,656 -43.3%
253.29
US$3,856,540 		53,656 -43.3% 253.29 US$3,856,540
2026-08-03 2026-08-03 PrS Proposed sale
2.7
JOLANDA MARIE HOWE

Officer

Officer
22,210
352.27
US$4,458,874 		22,210 352.27 US$4,458,874
2026-07-08 2026-07-06 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
21,485 -42.0%
115.26
US$2,889,068 		21,485 -42.0% 115.26 US$2,889,068
2026-07-08 2026-07-06 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
1,975 -1.0%
123.74
US$244,386 		1,975 -1.0% 123.74 US$244,386
2026-07-08 2026-07-06 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
4,181 -2.1%
122.34
US$511,504 		4,181 -2.1% 122.34 US$511,504
2026-07-08 2026-07-06 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
12,134 -5.7%
121.65
US$1,476,101 		12,134 -5.7% 121.65 US$1,476,101
2026-07-08 2026-07-06 PlS Planned sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
300 -0.7%
124.94
US$37,482 		300 -0.7% 124.94 US$37,482
2026-07-08 2026-07-06 PlS Planned sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
528 -1.2%
123.84
US$65,388 		528 -1.2% 123.84 US$65,388
2026-07-08 2026-07-06 PlS Planned sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
1,048 -2.4%
122.43
US$128,307 		1,048 -2.4% 122.43 US$128,307
2026-07-08 2026-07-06 PlS Planned sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
3,124 -6.6%
121.67
US$380,097 		3,124 -6.6% 121.67 US$380,097
2026-07-06 2026-07-06 PrS Proposed sale
3.2
CHRISTOPHER PEETZ

Officer; Director

Executive Director
20,000
122.27
US$2,445,434 		20,000 122.27 US$2,445,434
2026-07-06 2026-07-06 PrS Proposed sale
3.2
ERIC BJERKHOLT

Officer

Officer
5,000
122.25
US$611,270 		5,000 122.25 US$611,270
2026-07-02 2026-07-01 PlS Planned sale
2.7
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
2,721 -46.6%
120.00
US$326,520 		2,721 -46.6% 120.00 US$326,520
2026-07-01 2026-07-01 PrS Proposed sale
2.7
JOLANDA MARIE HOWE

Officer

Officer
2,721
120.00
US$326,520 		2,721 120.00 US$326,520
2026-06-18 2026-06-17 PlS Planned sale
2.7
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
2,594 -30.8%
101.95
US$264,458 		2,594 -30.8% 101.95 US$264,458
2026-06-17 2026-06-17 PrS Proposed sale
2.7
JOLANDA MARIE HOWE

Officer

Officer
2,594
101.95
US$264,458 		2,594 101.95 US$264,458
2026-06-09 2026-06-08 PlS Planned sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
1,567 -3.4%
95.12
US$149,053 		1,567 -3.4% 95.12 US$149,053
2026-06-09 2026-06-08 PlS Planned sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
1,175 -2.5%
93.95
US$110,391 		1,175 -2.5% 93.95 US$110,391
2026-06-09 2026-06-08 PlS Planned sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
2,258 -4.5%
92.84
US$209,633 		2,258 -4.5% 92.84 US$209,633
2026-06-08 2026-06-08 PrS Proposed sale
3.2
ERIC BJERKHOLT

Officer

Officer
5,000
93.81
US$469,073 		5,000 93.81 US$469,073
2026-06-08 2026-06-08 PrS Proposed sale
3.2
ERIC BJERKHOLT

Officer

Officer
5,000
93.81
US$469,073 		5,000 93.81 US$469,073
2026-06-02 2026-06-01 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
3,977 -100.0%
100.00
US$397,700 		3,977 -100.0% 100.00 US$397,700
2026-06-02 2026-06-01 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
883 -0.5%
99.66
US$88,000 		883 -0.5% 99.66 US$88,000
2026-06-02 2026-06-01 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
1,021 -0.5%
98.20
US$100,262 		1,021 -0.5% 98.20 US$100,262
2026-06-02 2026-06-01 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
1,973 -1.0%
97.56
US$192,486 		1,973 -1.0% 97.56 US$192,486
2026-06-02 2026-06-01 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
6,926 -3.4%
96.15
US$665,935 		6,926 -3.4% 96.15 US$665,935
2026-06-02 2026-06-01 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
16,595 -7.5%
95.34
US$1,582,167 		16,595 -7.5% 95.34 US$1,582,167
2026-06-02 2026-06-01 PlS Planned sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
2,602 -1.2%
94.64
US$246,253 		2,602 -1.2% 94.64 US$246,253
2026-06-01 2026-06-01 PrS Proposed sale
3.2
CHRISTOPHER PEETZ

Officer; Director

Executive Director
30,000
95.84
US$2,875,107 		30,000 95.84 US$2,875,107
2026-06-01 2026-06-01 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
3,977
100.00
US$397,700 		3,977 100.00 US$397,700
2026-05-18 2026-05-15 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
109.47
US$218,940 		2,000 -100.0% 109.47 US$218,940
2026-05-15 2026-05-15 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
109.47
US$218,940 		2,000 109.47 US$218,940
2026-04-16 2026-04-15 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
96.90
US$193,800 		2,000 -100.0% 96.90 US$193,800
2026-04-15 2026-04-15 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
96.90
US$193,800 		2,000 96.90 US$193,800
2026-03-17 2026-03-16 S Sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
7,287 -12.8%
91.98
US$670,243 		7,287 -12.8% 91.98 US$670,243
2026-03-17 2026-03-16 S Sale
2.7
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
4,732 -36.0%
91.98
US$435,239 		4,732 -36.0% 91.98 US$435,239
2026-03-17 2026-03-16 S Sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
40,985 -17.4%
91.98
US$3,769,714 		40,985 -17.4% 91.98 US$3,769,714
2026-03-17 2026-03-16 S Sale
2.6
Radovich Peter

PRESIDENT AND COO

Officer
16,515 -29.1%
91.98
US$1,519,015 		16,515 -29.1% 91.98 US$1,519,015
2026-03-17 2026-03-16 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
90.76
US$181,520 		2,000 -100.0% 90.76 US$181,520
2026-03-17 2026-03-16 S Sale
1.7
Quan Joanne

CHIEF MEDICAL OFFICER

Officer
7,287 -27.9%
91.98
US$670,243 		7,287 -27.9% 91.98 US$670,243
2026-03-17 2026-03-16 PrS Proposed sale
3.2
ERIC BJERKHOLT

Officer

Officer
7,287
92.64
US$675,068 		7,287 92.64 US$675,068
2026-03-17 2026-03-16 PrS Proposed sale
1.7
Joanne Quan

Officer

Officer
7,287
92.64
US$675,068 		7,287 92.64 US$675,068
2026-03-17 2026-03-16 PrS Proposed sale
2.6
Peter Radovich

Officer

Officer
16,515
92.64
US$1,529,950 		16,515 92.64 US$1,529,950
2026-03-17 2026-03-16 PrS Proposed sale
2.7
Jolanda Howe

Officer

Officer
4,732
92.64
US$438,372 		4,732 92.64 US$438,372
2026-03-17 2026-03-16 PrS Proposed sale
3.2
Christopher Peetz

Officer; Director

Executive Director
40,985
92.64
US$3,796,850 		40,985 92.64 US$3,796,850
2026-03-16 2026-03-16 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
90.76
US$181,520 		2,000 90.76 US$181,520
2026-02-17 2026-02-13 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
102.09
US$204,180 		2,000 -100.0% 102.09 US$204,180
2026-02-13 2026-02-13 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
102.09
US$204,180 		2,000 102.09 US$204,180
2026-02-03 2026-02-02 S Sale
2.7
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
968 -17.7%
103.30
US$99,998 		968 -17.7% 103.30 US$99,998
2026-02-03 2026-02-02 S Sale
2.6
Radovich Peter

PRESIDENT AND COO

Officer
2,631 -11.3%
103.30
US$271,792 		2,631 -11.3% 103.30 US$271,792
2026-02-03 2026-02-02 S Sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
9,108 -5.4%
103.30
US$940,888 		9,108 -5.4% 103.30 US$940,888
2026-02-03 2026-02-02 S Sale
2.7
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
968 -17.7%
103.30
US$99,998 		968 -17.7% 103.30 US$99,998
2026-02-02 2026-02-02 PrS Proposed sale
2.7
Jolanda Howe

Officer

Officer
968
103.80
US$100,478 		968 103.80 US$100,478
2026-02-02 2026-02-02 PrS Proposed sale
2.6
Peter Radovich

Officer

Officer
2,631
103.80
US$273,098 		2,631 103.80 US$273,098
2026-02-02 2026-02-02 PrS Proposed sale
3.2
Christopher Peetz

Officer; Director

Executive Director
9,108
103.80
US$945,410 		9,108 103.80 US$945,410
2026-01-28 2026-01-26 PrS Proposed sale
2.7
Jolanda Howe

Officer

Officer
842
96.92
US$81,607 		842 96.92 US$81,607
2026-01-28 2026-01-26 PrS Proposed sale
2.6
Peter Radovich

Officer

Officer
3,143
96.92
US$304,620 		3,143 96.92 US$304,620
2026-01-28 2026-01-26 PrS Proposed sale
3.2
Christopher Peetz

Officer; Director

Executive Director
6,831
96.92
US$662,061 		6,831 96.92 US$662,061
2026-01-28 2026-01-26 PrS Proposed sale
3.2
ERIC BJERKHOLT

Officer

Officer
1,053
96.92
US$102,057 		1,053 96.92 US$102,057
2026-01-27 2026-01-26 S Sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
6,831 -3.9%
96.19
US$657,088 		6,831 -3.9% 96.19 US$657,088
2026-01-27 2026-01-26 S Sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
1,053 -2.4%
96.19
US$101,290 		1,053 -2.4% 96.19 US$101,290
2026-01-27 2026-01-26 S Sale
2.7
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
842 -18.5%
96.19
US$80,994 		842 -18.5% 96.19 US$80,994
2026-01-27 2026-01-26 S Sale
2.6
Radovich Peter

PRESIDENT AND COO

Officer
3,143 -11.9%
96.19
US$302,331 		3,143 -11.9% 96.19 US$302,331
2026-01-27 2026-01-23 B Purchase
3.8
Heron Patrick J
Non-Executive Director
131,425 +40.1%
68.48
US$8,999,984 		131,425 +40.1% 68.48 US$8,999,984
2026-01-23 2026-01-22 S Sale
1.7
Quan Joanne

CHIEF MEDICAL OFFICER

Officer
1,822 -12.4%
93.33
US$170,039 		1,822 -12.4% 93.33 US$170,039
2026-01-23 2026-01-22 S Sale
3.2
Peetz Christopher

CHIEF EXECUTIVE OFFICER

Executive Director
7,098 -4.2%
93.33
US$662,422 		7,098 -4.2% 93.33 US$662,422
2026-01-23 2026-01-22 S Sale
2.7
Howe Jolanda

SVP, GLOBAL CONTROLLER

Officer
926 -23.3%
93.33
US$86,419 		926 -23.3% 93.33 US$86,419
2026-01-23 2026-01-22 S Sale
3.2
BJERKHOLT ERIC

CHIEF FINANCIAL OFFICER

Officer
1,421 -3.3%
93.33
US$132,615 		1,421 -3.3% 93.33 US$132,615
2026-01-23 2026-01-22 S Sale
2.6
Radovich Peter

PRESIDENT AND COO

Officer
2,382 -10.3%
93.33
US$222,301 		2,382 -10.3% 93.33 US$222,301
2026-01-21 2026-01-20 S Sale
1.7
Quan Joanne

CHIEF MEDICAL OFFICER

Officer
6,911 -37.9%
90.27
US$623,853 		6,911 -37.9% 90.27 US$623,853
2026-01-16 2026-01-15 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
2,000 -100.0%
90.99
US$181,980 		2,000 -100.0% 90.99 US$181,980
2026-01-15 2026-01-15 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
2,000
90.99
US$181,980 		2,000 90.99 US$181,980
2025-12-23 2025-12-22 PlS Planned sale
1.8
Ramasastry Saira
Non-Executive Director
5,000 -100.0%
80.00
US$400,000 		5,000 -100.0% 80.00 US$400,000
2025-12-22 2025-12-22 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
5,000
80.00
US$400,000 		5,000 80.00 US$400,000
2025-12-23 2025-12-19 PlS Planned sale
1.2
GREY MICHAEL G
Non-Executive Director
50,000 -100.0%
78.00
US$3,900,000 		50,000 -100.0% 78.00 US$3,900,000
Explore more

More insider trading research around Mirum Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America